The antioxidant defense protein ferritin is a novel and specific target for pentaerithrityl tetranitrate in endothelial cells

被引:53
作者
Oberle, S [1 ]
Schwartz, P [1 ]
Abate, A [1 ]
Schröder, H [1 ]
机构
[1] Univ Halle Wittenberg, Sch Pharm, Dept Pharmacol & Toxicol, D-06099 Halle, Saale, Germany
关键词
D O I
10.1006/bbrc.1999.0941
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The organic nitrate pentaerithrityl tetranitrate (PETN) is known to exert long-term antioxidant and antiatherogenic effects by as yet unidentified mechanisms. In porcine aortic endothelial cells, a 24 h incubation with PETN (1-100 mu M) or its metabolite pentaerithrityl trinitrate (PETriN) increased levels of the antioxidant protein ferritin up to three-fold over basal, whereas isosorbide dinitrate and isosorbide-5-mononitrate were without significant effect under these conditions. PETriN-induced ferritin expression was blocked by the NO scavenger PTIO but remained unaltered in the presence of ODQ, an inhibitor of soluble guanylyl cyclase. 8-Bromo cyclic GMP and dibutyryl cyclic GMP did not influence basal ferritin synthesis. The iron chlelator desferrioxamine abolished ferritin induction by PETriN. Our results show that PETN or its active metabolite PETriN induce ferritin synthesis through NO- and iron-dependent but cyclic GMP-independent pathways. Increased activity of ferritin may contribute to, and at least in part explain, the specific antiatherogenic and antioxidant action of PETN. (C) 1999 Academic Press.
引用
收藏
页码:28 / 34
页数:7
相关论文
共 41 条
[11]  
Feelisch M., 1996, M ETHODS NITRIC OXID, P71
[12]   Unexpected, tolerance-devoid vasomotor and platelet actions of pentaerythrityl tetranitrate [J].
Fink, B ;
Bassenge, E .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1997, 30 (06) :831-836
[13]   THE NITROVASODILATORS - NEW IDEAS ABOUT OLD DRUGS [J].
HARRISON, DG ;
BATES, JN .
CIRCULATION, 1993, 87 (05) :1461-1467
[14]   Ferritins: Molecular properties, iron storage function and cellular regulation [J].
Harrison, PM ;
Arosio, P .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1996, 1275 (03) :161-203
[15]   Pentaerithrityl tetranitrate and its phase I metabolites are potent activators of cellular cyclic GMP accumulation [J].
Hinz, B ;
Kuntze, U ;
Schröder, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 253 (03) :658-661
[16]  
JUCKETT MB, 1995, AM J PATHOL, V147, P782
[17]   BODY IRON STORES AND PRESENCE OF CAROTID ATHEROSCLEROSIS - RESULTS FROM THE BRUNECK STUDY [J].
KIECHL, S ;
AICHNER, F ;
GERSTENBRAND, F ;
EGGER, G ;
MAIR, A ;
RUNGGER, G ;
SPOGLER, F ;
JAROSCH, E ;
OBERHOLLENZER, F ;
WILLEIT, J .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (10) :1625-1630
[18]   NITROGEN OXIDE-INDUCED AUTOPROTECTION IN ISOLATED RAT HEPATOCYTES [J].
KIM, YM ;
BERGONIA, H ;
LANCASTER, JR .
FEBS LETTERS, 1995, 374 (02) :228-232
[19]   Effects of nonintermittent treatment of rabbits with pentaerythritol tetranitrate on vascular reactivity and superoxide production [J].
Kojda, G ;
Hacker, A ;
Noack, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 355 (01) :23-31
[20]   IN-VIVO EFFECTS OF PENTAERYTHRITYL-TETRANITRATE AND ISOSORBIDE-5-MONONITRATE ON THE DEVELOPMENT OF ATHEROSCLEROSIS AND ENDOTHELIAL DYSFUNCTION IN CHOLESTEROL-FED RABBITS [J].
KOJDA, G ;
STEIN, D ;
KOTTENBERG, E ;
SCHNAITH, EM ;
NOACK, E .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (05) :763-773